SHIC

Eight Winners of the 2022 Medical Innovation Challenge Announced at Defense TechConnect Innovation Summit & Expo

Retrieved on: 
Thursday, September 29, 2022
Hospital, University, Convention center, Global Innovation through Science and Technology initiative, Therapy, MTEC, Department, Saliva, Brain, Acquisition, Compliance, Centre for the Advancement of Sustainable Medical Innovation, Partnership, Industry, Stroke, Government, Infection, Mental health, Intelligence, ATI, Defense, Student, Technology, LAUNCH (Innovation Challenge), ANSER, Solution, Extracellular matrix, MCDC, Defence Analytical Services and Advice, Anxiety, Ultimate tensile strength, Atrial fibrillation, DTC, Music, Research, U.S. Department of Defense Strategy for Operating in Cyberspace, SHIC, Bone fracture, Depression, Medical imaging, Mobile phone, Pharmaceutical industry, Security (finance), Mass

WASHINGTON,  Sept. 29, 2022  /PRNewswire-PRWeb/ -- Advanced Technology International (ATI), TechConnect and four medtech industry consortia today announced the seven winners of the 2022 Medical Innovation Challenge as well as an eighth winner from innovations created by students. Selected from a field of 25 finalists, winners were presented a total $250,000 in cash prizes at the Defense TechConnect (DTC) Innovation Summit & Expo, the nation's largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements.

Key Points: 
  • WASHINGTON, Sept. 29, 2022 /PRNewswire-PRWeb/ -- Advanced Technology International (ATI), TechConnect and four medtech industry consortia today announced the seven winners of the 2022 Medical Innovation Challenge as well as an eighth winner from innovations created by students.
  • Selected from a field of 25 finalists, winners were presented a total $250,000 in cash prizes at the Defense TechConnect (DTC) Innovation Summit & Expo , the nation's largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements.
  • The Defense TechConnect (DTC) Innovation Summit & Expo is the nation's largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements.
  • DTC is proud to be one of the original innovation hubs to support the Department of Defense and its missions.

Defense TechConnect 2022 Innovation Summit & Expo to Feature Six Innovation Challenges for Accelerating Cutting-edge Technologies to Support the National Defense Strategy

Retrieved on: 
Thursday, September 8, 2022
National Science Foundation, MTEC, Technology, Science, Research, Convention center, Consortium, National Harbor, Maryland, DTC, National Security Innovation Network, ATI, ANSER, University, Global Innovation through Science and Technology initiative, Government, Engineering statistics, Department, Intelligence, U.S. Department of Defense Strategy for Operating in Cyberspace, Defense, Create, Industry, Defence Analytical Services and Advice, Partnership, National Center for Telehealth & Technology, Mass, VLC, Investment, Acceleration, SBIR, Privacy, Homeland, RISE, ADC, Acquisition, HSTC, Aviation, AI, Immersion, Artificiality, NSC, MCDC, LAUNCH (Innovation Challenge), Therapy, SHIC, Video game, Management, Security (finance), Pharmaceutical industry, Medical device, MD

WASHINGTON, Sept. 8, 2022   /PRNewswire-PRWeb/ -- 

Key Points: 
  • To be held Sept. 27-29, 2022, the Defense TechConnect 2022 Innovation Summit & Expo's six Innovation Challenges will feature "Shark Tank"-style pitches by startups, universities and national labs competing for more than $500,000 in total prizes.
  • The Defense TechConnect (DTC) 2022 Innovation Summit & Expo , the nation's largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements, will convene on Sept. 27-29, 2022, at Gaylord National Hotel & Convention Center, 201 Waterfront St., National Harbor, MD.
  • DTC also will feature its own innovation spotlights program featuring universities and startups presenting over the three-day program."
  • The Defense TechConnect (DTC) Innovation Summit & Expo is the nation's largest annual gathering of non-traditional, dual-use emerging technologies aligned with government priority requirements.

Medical Innovation Challenge Announces Contenders For $200,000 Award

Retrieved on: 
Thursday, August 11, 2022
Multimedia, ATI, ANSER, Industry, Defence Analytical Services and Advice, Challenge, Government, Doctor of Philosophy, Global Innovation through Science and Technology initiative, View, SHIC, Partnership, MTEC, Federation, Entrepreneurship, Pharmaceutical industry, Research

"Prototype advancement of medical technology will undoubtedly have a profound impact on the capabilities that we are able to provide far forward in a military setting.

Key Points: 
  • "Prototype advancement of medical technology will undoubtedly have a profound impact on the capabilities that we are able to provide far forward in a military setting.
  • For more information about this Challenge or to register to attend, visit: https://events.techconnect.org/DTCFall/medical_innovation_challenge/ .
  • With 25+ years of experience connecting emerging technologies with unique funding and partnership opportunities, TechConnect boasts the most robust research and innovation network in the world.
  • It employs a broad scope of tools to deliver top technologies, including open innovation programs, conferences, and open-access publications.

ATI Augments Medical Innovation Challenge Prize, Stands Up $250,000 Non-Dilutive Award for Innovators

Retrieved on: 
Thursday, April 28, 2022
Medicine, Challenge, Defence Analytical Services and Advice, Consortium, Commercialization, Technology, Partnership, Defense, Therapy, Centre for the Advancement of Sustainable Medical Innovation, ANSER, SHIC, Multimedia, View, Research, ATI, Industry, Government, Mass, Global Innovation through Science and Technology initiative, MTEC, MCDC, Pharmaceutical industry, Renewable energy

"As we emerge from a global pandemic, the timing has never been better to accelerate medical innovation.

Key Points: 
  • "As we emerge from a global pandemic, the timing has never been better to accelerate medical innovation.
  • The Medical Innovation Challenge seeks to harness the power of groundbreaking medical solutions, establish meaningful paths forward for top innovators, and ultimately improve outcomes for the nation," said Matthew Laudon, Vice President TechConnect Division, ATI.
  • Qualified applicants receive a 12-month membership opportunity to the Medical CBRN Defense Consortium (MCDC), Countering Weapons of Mass Destruction (CWMD) Consortium, Medical Technology Enterprise Consortium (MTEC), and Senior Healthcare Innovation Consortium (SHIC).
  • "The Medical Technology Enterprise Consortium (MTEC) eagerly supports the Medical Innovation Challenge in attracting the best and brightest medical innovators to pitch and connect their technology with leading corporate, investment, and federal sponsors," said Rick Satcher, Director of Commercialization for MTEC.

PharmaVentures and Shinhan Investment Corp sign Memorandum of Understanding to strengthen global collaboration for the Korean biopharma industry

Retrieved on: 
Thursday, November 18, 2021
CEO, Industry, IPO, History, MOU, SHIC, GIB, Fine chemical, Airline

OXFORD, England, Nov. 18, 2021 /PRNewswire/ -- PharmaVentures is delighted to announce it has signed a Memorandum of Understanding (MOU) with the leading Korean investment bank, Shinhan Investment Corp Group & Global Investment Banking Group (SHIC).

Key Points: 
  • OXFORD, England, Nov. 18, 2021 /PRNewswire/ -- PharmaVentures is delighted to announce it has signed a Memorandum of Understanding (MOU) with the leading Korean investment bank, Shinhan Investment Corp Group & Global Investment Banking Group (SHIC).
  • Through this MOU, PharmaVentures and Shinhan Investment Corp intend to collaborate closely to provide a much broader range of capabilities and services to both Korean biotech companies and global biopharma companies looking at the Korean biotech opportunity.
  • The collaboration intends to give Korean companies better access to global markets, and for international companies to gain greater access to the Korean bio industry and its capital markets.
  • Examples of PharmaVentures work with Korean clients include:
    Advisor toIntoCell throughout the initiation, negotiation, and execution of this multi-target collaboration agreement with Cellectar

PharmaVentures and Shinhan Investment Corp sign Memorandum of Understanding to strengthen global collaboration for the Korean biopharma industry

Retrieved on: 
Thursday, November 18, 2021
CEO, Industry, IPO, History, MOU, SHIC, GIB, Fine chemical, Airline

OXFORD, England, Nov. 18, 2021 /PRNewswire/ -- PharmaVentures is delighted to announce it has signed a Memorandum of Understanding (MOU) with the leading Korean investment bank, Shinhan Investment Corp Group & Global Investment Banking Group (SHIC).

Key Points: 
  • OXFORD, England, Nov. 18, 2021 /PRNewswire/ -- PharmaVentures is delighted to announce it has signed a Memorandum of Understanding (MOU) with the leading Korean investment bank, Shinhan Investment Corp Group & Global Investment Banking Group (SHIC).
  • Through this MOU, PharmaVentures and Shinhan Investment Corp intend to collaborate closely to provide a much broader range of capabilities and services to both Korean biotech companies and global biopharma companies looking at the Korean biotech opportunity.
  • The collaboration intends to give Korean companies better access to global markets, and for international companies to gain greater access to the Korean bio industry and its capital markets.
  • Examples of PharmaVentures work with Korean clients include:
    Advisor toIntoCell throughout the initiation, negotiation, and execution of this multi-target collaboration agreement with Cellectar